Clinical and economic outcomes associated with the use of fluticasone propionate 250 mcg and salmeterol 50 mcg combination versus tiotropium bromide 18 mcg as initial maintenance treatment for chronic obstructive pulmonary disease in managed care.
Christopher F BellAnna D CoutinhoEileen FarrellyTasneem LokhandwalaPamela Landsman-BlumbergPublished in: Journal of medical economics (2018)
Few clinical and economic differences between subjects initiating maintenance therapy with FSC or TIO were observed.